Abstract: An implantable neurostimulator includes a lead comprising a plurality of electrodes at a distal end, and an implant body including electronics for controlling operation of the electrodes. An electrical connector establishes an electrical connection between the electronics and the electrodes. The implant body includes a first portion of the electrical connector, and the proximal end of the lead includes a second portion of the electrical connector. The first and second portions of the electrical connector are connectable to establish the electrical connection between the electronics and the electrodes. The lead is configured for initial implantation in the patient and the implant body is configured for subsequent implantation in the patient. The electrical connector is configured so that the connection of the first and second portions can be performed with the implant body and the lead positioned at a surgical site in the patient.

Abstract: An implantable neurostimulator includes a lead comprising a plurality of electrodes at a distal end, and an implant body including electronics for controlling operation of the electrodes. An electrical connector establishes an electrical connection between the electronics and the electrodes. The implant body includes a first portion of the electrical connector, and the proximal end of the lead includes a second portion of the electrical connector. The first and second portions of the electrical connector are connectable to establish the electrical connection between the electronics and the electrodes. The lead is configured for initial implantation in the patient and the implant body is configured for subsequent implantation in the patient. The electrical connector is configured so that the connection of the first and second portions can be performed with the implant body and the lead positioned at a surgical site in the patient.

Abstract: Methods of improving craniofacial pain or stroke recovery via neurostimulation are provided. Methods include first screening the subject for neurostimulation based on the subject's responsiveness to a block of the sphenopalatine ganglion or branch thereof.

Abstract: An implantable neurostimulator includes a lead comprising a plurality of electrodes at a distal end, and an implant body including electronics for controlling operation of the electrodes. An electrical connector establishes an electrical connection between the electronics and the electrodes. The implant body includes a first portion of the electrical connector, and the proximal end of the lead includes a second portion of the electrical connector. The first and second portions of the electrical connector are connectable to establish the electrical connection between the electronics and the electrodes. The lead is configured for initial implantation in the patient and the implant body is configured for subsequent implantation in the patient. The electrical connector is configured so that the connection of the first and second portions can be performed with the implant body and the lead positioned at a surgical site in the patient.

Abstract: The present invention provides a drug delivery system that includes a housing configured to contain one or more dispensers. Each dispenser includes an activation mechanism, a nozzle configured to direct the medicament to a predetermined area in the nasal passageway. The nozzles may be configured to create a spray pattern that is about 50-degrees to direct the delivery of a medicament to the sphenopalatine ganglion.

Abstract: A system and method of tracking medical products provides for associating a group of medical products with a group location based on a group radio frequency identification (RF ID) device signal, where the group includes a first unit and a second unit. The first unit is associated with a first remote location based on a first unit RF ID device signal. The method further provides for associating the second unit with a second remote location based on a second unit RF ID device signal. The signals uniquely identify the units and the group.

Abstract: The invention relates to methods and instruments for relieving spinal nerve impingement disorders (SNIDs) and symptoms associated with SNIDs. The methods involve separating a spinal neural structure and a transforaminal or peliforaminal ligament.

Abstract: A system and method of tracking medical products provides for associating a group of medical products with a group location based on a group radio frequency identification (RF ID) device signal, where the group includes a first unit and a second unit. The first unit is associated with a first remote location based on a first unit RF ID device signal. The method further provides for associating the second unit with a second remote location based on a second unit RF ID device signal. The signals uniquely identify the units and the group.

Abstract: Compositions useful for treating inflammatory diseases including arthritis are disclosed which comprise cetyl myristoleate compounds or related compounds and at least one compound useful for treatment of inflammatory disease, such as tetracycline compounds, Cox-2 inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, local anaesthetics, chelating agents, matrix metalloprotease inhibitors, inhibitors of inflammatory cytokines, glucosamine, chondroitin sulfate and collagen hydrolysate. Also disclosed are pharmaceutical compositions and methods of treatment for inflammatory disease and local inflammation and dermal irritation. Also disclosed are compositions including tetracycline and at least one compound useful for treatment of inflammatory disease.

Abstract: The invention relates to methods of relieving spinal nerve impingement disorders (SNIDs) and symptoms associated with SNIDs. The methods involve percutaneously inserting an instrument into a spinal neuroforamen to separate a spinal neural structure and a non-neural tissue. The invention further relates to methods of assessing the physical location of spinal neural structure impingement. These methods can be used in conjunction with the methods described herein or with known surgical or therapeutic methods to provide relief to subjects afflicted with a SNID.

Abstract: Compositions useful for treating inflammatory diseases including arthritis are disclosed which comprise cetyl myristoleate compounds or related compounds and at least one compound useful for treatment of inflammatory disease, such as tetracycline compounds, Cox-2 inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, local anaesthetics, chelating agents, matrix metalloprotease inhibitors, inhibitors of inflammatory cytokines, glucosamine, chondroitin sulfate and collagen hydrolysate. Also disclosed are pharmaceutical compositions and methods of treatment for inflammatory disease and local inflammation and dermal irritation. Also disclosed are compositions including tetracycline and at least one compound useful for treatment of inflammatory disease.

Abstract: Novel modalities are introduced to treat joint and cartilage ischemia and related pathologies to improve outcome in the treatment of arthropathies and spondylopathies. The invention includes compositions, materials or devices which will improve oxygen, substrate and nutrient delivery to joint tissues and modalities to decrease the degradation of joint tissues by inflammatory and other destructive processes.

Abstract: A method and apparatus for the delivery, administration and application of themes to a cellular telephone device. The apparatus, in one embodiment, comprises an inbox to receive a multimedia message (MM) containing a theme, a filing logic to place the MM in a themes folder, a themes folder available to the user to browse the theme MMs, and a client-side application to apply the theme to the user's cellular telephone device. In one embodiment, the apparatus includes notification logic to notify a web page associated with the user to change its display to match the theme applied by the user to the cellular telephone device.

Abstract: The invention includes methods, kits, compositions, and apparatus for intranasal administration of a compound such as a pharmaceutically active agent in a targeted manner. Such compounds can be delivered preferentially to a component of the central nervous system (CNS) such as the brain, the spinal cord, or cerebrospinal fluid. Such compounds can alternatively be administered preferentially to the systemic circulation of a human patient. The compound can be administered to either side of the blood-brain barrier by directing administration of the compound to portions of the nasal epithelium that overlie or are near an intranasal nerve structure, and intranasal blood vessel, or both.

Abstract: The weather-resistant shelter for a lighting fixture is primarily designed for use in outdoor environments. The shelter comprises upper and lower hood segments attached to a backing plate. A horizontal gap between the hood segments allows cooling air to circulate around electrical components within the shelter while protecting the electrical components from moisture. A second embodiment comprises a backing plate sized and dimensioned to house certain electrical components. In an additional embodiment, the backing plate is divided into independent upper and lower halves for increased flexibility. The device may be specifically configured to accommodate a bulb of 60 watts or more.

Abstract: A system and method of tracking medical products provides for associating a group of medical products with a group location based on a group radio frequency identification (RF ID) device signal, where the group includes a first unit and a second unit. The first unit is associated with a first remote location based on a first unit RF ID device signal. The method further provides for associating the second unit with a second remote location based on a second remote location based on a second unit RF ID device signal. The signals uniquely identify the units and the group.

Abstract: Compositions useful for treating inflammatory diseases including arthritis are disclosed which comprise cetyl myristoleate compounds or related compounds and at least one compound useful for treatment of inflammatory disease, such as tetracycline compounds, Cox-2 inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, local anaesthetics, chelating agents, matrix metalloprotease inhibitors, inhibitors of inflammatory cytokines, glucosamine, chondroitin sulfate and collagen hydrolysate. Also disclosed are pharmaceutical compositions and methods of treatment for inflammatory disease and local inflammation and dermal irritation. Also disclosed are compositions including tetracycline and at least one compound useful for treatment of inflammatory disease.

Abstract: Compositions useful for treating inflammatory diseases including arthritis are disclosed which comprise cetyl myristoleate compounds or related compounds and at least one compound useful for treatment of inflammatory disease, such as tetracycline compounds, Cox-2 inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, local anaesthetics, chelating agents, matrix metalloprotease inhibitors, inhibitors of inflammatory cytokines, glucosamine, chondroitin sulfate and collagen hydrolysate. Also disclosed are pharmaceutical compositions and methods of treatment for inflammatory disease and local inflammation and dermal irritation. Also disclosed are compositions including tetracycline and at least one compound useful for treatment of inflammatory disease.

Abstract: An endotracheal tube insertion system includes a formable shaft having sufficient stiffness to hold a formed shape and having a plurality of longitudinally extending passageways defined therethrough. The instrument further includes a housing connected to the first end of the formable shaft. An image guide cable is disposed in a first longitudinally extending passageway and is optically connected to an eyepiece which is affixed to the first end of the housing. A light source is attached to the second end of the formable shaft proximate the second end of the image guide cable. A baffle member is attached to the second end of the formable shaft proximate to a second longitudinally extending passageway and has an opening directed toward the first longitudinally extending passageway. A fluid port is in fluid communication with the second passageway. A suction port is also provided in fluid communication with a third longitudinally extending passageway.